2024 ICD-10-CM Diagnosis Code C44.99

by

Other specified malignant neoplasm of skin, unspecified

  • C44.99 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2024 edition of ICD-10-CM C44.99 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of C44.99 – other international versions of ICD-10 C44.99 may differ.

The following code(s) above C44.99 contain annotation back-references

 that may be applicable to C44.99:

  • C00-D49  Neoplasms
  • C44  Other and unspecified malignant neoplasm of skin

Approximate Synonyms

  • Cancer of the skin, adenocarcinoma
  • Cancer, dermatofibrosarcoma protuberans
  • Dermatofibrosarcoma protuberans
  • Extramammary paget’s disease of skin
  • Extramammary pagets of skin
  • Microcystic adnexal carcinoma
  • Primary adenocarcinoma of skin
  • Sebaceous adenocarcinoma
  • Sebaceous carcinoma

ICD-10-CM C44.99 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

  • 606 Minor skin disorders with mcc
  • 607 Minor skin disorders without mcc

Convert C44.99 to ICD-9-CMCode History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change

Diagnosis Index entries containing back-references to C44.99: